MedPath

Allergy Testing of Patients Labeled as Penicillin Allergic

Completed
Conditions
Drug Hypersensitivity
Registration Number
NCT02983630
Lead Sponsor
Albany Medical College
Brief Summary

Patients labeled as penicillin allergic, rarely have this confirmed and being labeled as "penicillin allergic" is associated with increased health care costs, adverse effects and antibiotic resistance. The investigators will recruit participants from primary care practices labeled as penicillin allergic and offer allergy testing. The aim of this study is to develop a community, outpatient program for evaluation of penicillin allergy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  1. Labeled as having penicillin or amoxicillin allergy
  2. Family history of penicillin allergy
Exclusion Criteria
  1. History of beta-lactam associated toxic epidermal necrolysis/Stevens Johnson syndrome to penicillin or amoxicillin
  2. History of Drug induced Eosinophilia with Systemic Symptoms (DRESS)
  3. History of drug induced: autoimmune hepatitis/interstitial nephritis, or hemolytic anemia
  4. Poorly controlled asthma or heart disease
  5. Currently pregnant
  6. Unable to discontinue certain medications that may interfere with testing including (antihistamines, steroids, beta-blockers, tricyclic antidepressants, omalizumab)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Allergy testing for penicillin allergy results6 months
Secondary Outcome Measures
NameTimeMethod
Participant satisfaction after allergy testing with follow-up questionnaireWithin 6 months following testing

A questionnaire will be provided to participants to review their experience with penicillin allergy testing, whether they will take penicillin in the future and if it is valuable information to be tested. Answers will be yes and no. This information will tell us

Development of new drug allergies following negative testing questionnaire6 months-2 years

Follow-up questionnaire will be sent to participants to evaluate whether they have needed any antibiotics and if so, whether they've had any reactions. This will be two yes/no questions to assess the incidence of development of new allergic reaction following negative testing.

Trial Locations

Locations (1)

Albany Medical College Allergy, Asthma and Immunology Center

🇺🇸

Albany, New York, United States

© Copyright 2025. All Rights Reserved by MedPath